This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Assault by other specified means
VWXY20_ASSAU_OTHER_SPECIFE_MEANS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
356 |
4. Check minimum number of eventsNone |
356 |
5. Include endpointsNone |
356 |
6. Filter based on genotype QC (FinnGen only) |
356 |
Control definitions (FinnGen only)
- Control exclude
- VWXY20_ASSAULT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X85-Y09
Similar endpoints
↥List of similar endpoints to
Assault by other specified means
based on the number of shared cases.
Similar with more cases:
- Assault
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 356 | 167 | 189 |
| Unadjusted period prevalence (%) | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | 40.06 | 40.06 | 40.06 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 310
- Matched controls
- 3100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y08.9
ICD-10 Finland
Assault by other specified means by unknown person
+∞
122.1
109
*
Y08.8
ICD-10 Finland
Assault by other specified means by other known person
+∞
117.3
105
*
T74.1
ICD-10 Finland
Physical abuse
64.5
93.6
107
25
Y08.0
ICD-10 Finland
Assault by other specified means by spouse or partner
+∞
55.9
52
*
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
632.6
55.4
53
*
S06.0
ICD-10 Finland
Concussion
8.5
41.3
100
164
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
10.8
38.4
78
93
T36
ICD-10 Finland
Poisoning by systemic antibiotics
12.6
36.1
67
66
F10.09
ICD-10 Finland
Alcohol intoxication UNS
21.3
33.1
49
27
Y08.2
ICD-10 Finland
Assault by other specified means by friend
+∞
32.9
31
*
Y07
ICD-10 Finland
Other maltreatment
+∞
31.8
30
*
N05AH04
ATC
quetiapine; oral
5.2
31.8
119
332
S01.0
ICD-10 Finland
Open wound of scalp
9.0
30.4
68
94
N06AX11
ATC
mirtazapine; oral
4.3
29.8
151
564
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
12.8
29.7
54
50
Y09
ICD-10 Finland
Assault by unspecified means
320.2
29.3
29
*
N05BA04
ATC
oxazepam; oral
4.5
28.6
128
421
X59
ICD-10 Finland
Exposure to unspecified factor
4.6
26.8
111
334
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
+∞
26.4
25
*
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
20.4
25.5
38
21
N05BA01
ATC
diazepam; systemic, rectal
5.6
25.5
83
191
N07BB01
ATC
disulfiram; oral
9.8
24.5
51
61
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.0
24.3
123
440
B18.2
ICD-10 Finland
Chronic viral hepatitis C
20.2
24.1
36
20
F10.25
ICD-10 Finland
Alcohol dependence continuous use
27.3
23.6
32
13
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.5
21.8
88
251
AA1AD
NOMESCO Finland
CT of head and brain
4.2
21.8
96
298
P15
ICPC
Chronic alcohol abuse
11.0
20.8
40
41
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.5
19.3
61
133
F10.20
ICD-10 Finland
Alcohol dependence currently independent
14.1
18.9
32
25
N05CF01
ATC
zopiclone; oral
3.3
18.2
114
462
N06AB04
ATC
citalopram; systemic
3.6
18.2
99
360
N05CD07
ATC
temazepam; oral
5.8
18.1
54
109
N03AE01
ATC
clonazepam; systemic
8.0
17.8
41
58
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
20.1
17.6
26
14
P19
ICPC
Drug abuse
17.3
17.4
27
17
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
53.2
17.2
20
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
11.0
16.3
31
31
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
15.6
16.1
26
18
AA3AD
NOMESCO Finland
CT of face
63.4
15.9
18
*
S22.3
ICD-10 Finland
Fracture of rib
7.3
15.7
38
58
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.5
15.1
40
69
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
33.6
15.0
19
6
N06AX16
ATC
venlafaxine; oral
3.5
15.0
79
275
F10.24
ICD-10 Finland
Alcohol depence active use
19.6
14.9
22
12
M54.5
ICD-10 Finland
Low back pain
2.8
14.8
131
647
N03AX12
ATC
gabapentin; oral
3.9
14.8
65
195
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
+∞
14.7
14
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.6
14.7
193
1198
NA1AD
NOMESCO Finland
Cervical spine CT examination
8.4
14.5
32
42
S18
ICPC
Laceration/cut
2.7
14.5
130
650
Z72.2
ICD-10 Finland
Drug use
18.6
14.0
21
12
K02.1
ICD-10 Finland
Caries of dentine
2.6
13.7
225
1554
T00.9
ICD-10 Finland
Multiple superficial injuries, unspecified
78.6
13.7
15
*
X58
ICD-10 Finland
Exposure to other specified factors
3.3
13.7
79
294
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
17.2
13.7
21
13
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
+∞
13.6
13
*
Z2446
NOMESCO Finland
Social worker
5.4
13.4
41
85
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
5.2
13.4
42
90
N05AH03
ATC
olanzapine; systemic
4.5
13.2
48
120
S00.7
ICD-10 Finland
Multiple superficial injuries of head
29.8
13.1
17
6
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.6
13.1
63
204
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
23.8
13.0
18
8
N02BE01
ATC
paracetamol; systemic, rectal
3.1
12.8
266
2056
EBA00
NOMESCO Finland
Extraction of tooth
2.5
12.8
138
748
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.7
12.7
24
24
N03AX16
ATC
pregabalin; oral
3.1
12.7
78
302
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
21.1
12.6
18
9
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
21.1
12.6
18
9
WX110
NOMESCO Finland
Local anesthesy
2.7
12.5
243
1789
ZXD05
NOMESCO Finland
Urgent procedure
2.6
12.5
119
602
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.5
12.4
29
42
S01.51
ICD-10 Finland
Open wound on lip
16.8
12.3
19
12
K04.0
ICD-10 Finland
Pulpitis
3.6
12.2
58
185
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
67.5
11.7
13
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
67.5
11.7
13
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
11.6
130
711
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
8.4
11.6
25
32
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
11.6
125
672
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
7.0
11.6
28
43
X99.9
ICD-10 Finland
Assault by sharp object by unknown person
+∞
11.5
11
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.2
11.4
64
231
N06AB03
ATC
fluoxetine; oral
3.4
11.3
57
190
DHD10
NOMESCO Finland
Closed reduction of fracture of nose
17.9
11.3
17
10
T90.5
ICD-10 Finland
Sequelae of intracranial injury
17.9
11.3
17
10
SPAT1227
SPAT
Substance abuse rehabilitation
21.0
11.2
16
8
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
21.0
11.2
16
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
11.2
52
162
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
26.1
11.2
15
6
Z72.1
ICD-10 Finland
Alcohol use
26.1
11.2
15
6
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
11.8
11.2
20
18
P29
ICPC
Psychological sympt/compl other
4.1
11.1
44
120
A01
ICPC
Pain general/multiple sites
5.5
11.0
32
63
N06AB06
ATC
sertraline; oral
3.4
10.9
55
184
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
29.2
10.8
14
5
SPAT1272
SPAT
Drug screening
22.4
10.8
15
7
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
22.4
10.8
15
7
W19
ICD-10 Finland
Unspecified fall
4.1
10.7
42
113
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
62.2
10.7
12
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
10.5
55
189
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.3
10.5
39
100
Y00.9
ICD-10 Finland
Assault by blunt object by unknown person
+∞
10.5
10
*
N03AG01
ATC
valproic acid; systemic, rectal
4.5
10.4
37
91
-1
NOMESCO Finland
NA
2.3
10.3
138
811
SPAT1265
SPAT
Breathalyser
13.7
10.3
17
13
P16
ICPC
Acute alcohol abuse
11.9
10.2
18
16
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
9.6
10.2
20
22
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
10.2
151
931
WX290
NOMESCO Finland
Other blockade of nerve
2.2
10.2
185
1246
C07AA05
ATC
propranolol; systemic
2.7
10.1
78
343
R06.0
ICD-10 Finland
Dyspnoea
2.8
10.1
73
310
N03AX09
ATC
lamotrigine; oral
5.0
10.0
32
70
N05AF03
ATC
chlorprothixene; systemic
6.9
9.9
24
37
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.8
9.9
43
127
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
27.0
9.9
13
5
N05BA12
ATC
alprazolam; oral
3.8
9.7
42
124
W10
ICD-10 Finland
Fall on and from stairs and steps
5.7
9.6
27
51
N06AB10
ATC
escitalopram; oral
2.5
9.6
91
447
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
5.9
9.6
26
47
M79.6
ICD-10 Finland
Pain in limb
2.3
9.6
113
621
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
9.6
151
945
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.4
9.5
48
160
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.3
9.5
104
550
N02AA05
ATC
oxycodone; systemic
4.0
9.4
38
105
W17
ICD-10 Finland
Other fall from one level to another
5.8
9.4
26
48
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
22.5
9.4
13
6
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
+∞
9.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
9.4
126
734
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.6
9.3
76
343
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.4
9.3
33
81
J01FF01
ATC
clindamycin; systemic
2.4
9.3
95
485
SPAT1263
SPAT
Sampling
2.1
9.2
145
904
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
3.5
9.1
43
136
S20.2
ICD-10 Finland
Contusion of thorax
5.0
9.0
28
60
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
24.9
9.0
12
5
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
6.3
8.9
23
39
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.1
8.9
191
1348
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.1
8.9
51
187
ZY000
NOMESCO Finland
Hospital inpatient
14.6
8.8
14
10
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
14.6
8.8
14
10
SAA01
NOMESCO Finland
Simple examination of mouth
2.3
8.7
246
1942
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
51.4
8.7
10
*
S00.8
ICD-10 Finland
Superficial injury of other parts of head
9.4
8.6
17
19
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
9.4
8.6
17
19
EBA30
NOMESCO Finland
Excision of root of tooth
4.8
8.6
28
63
R11
ICD-10 Finland
Nausea and vomiting
3.9
8.6
35
98
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
7.7
8.6
19
26
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.6
8.6
29
68
P01
ICPC
Feeling anxious/nervous/tense
2.7
8.5
62
263
A46
ICD-10 Finland
Erysipelas
3.1
8.5
47
167
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
13.3
8.4
14
11
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
8.4
88
451
SPAT1254
SPAT
Administration of medicine
2.9
8.4
52
200
Y08
ICD-10 Finland
Assault by other specified means
+∞
8.4
8
*
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
+∞
8.4
8
*
A02BC02
ATC
pantoprazole; systemic
2.0
8.3
177
1228
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
8.3
103
572
K08.3
ICD-10 Finland
Retained dental root
4.3
8.2
30
76
R51.80
ICD-10 Finland
Headache
2.5
8.1
67
303
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
8.1
8.0
17
22
F61.0
ICD-10 Finland
Mixed personality disorders
8.1
8.0
17
22
S09.9
ICD-10 Finland
Unspecified injury of head
13.5
7.9
13
10
N05AX08
ATC
risperidone; systemic
3.6
7.9
35
106
N05BA02
ATC
chlordiazepoxide; systemic
9.8
7.9
15
16
F43.01
ICD-10 Finland
Acute stress reaction moderate
9.8
7.9
15
16
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
46.1
7.7
9
*
C03CA01
ATC
furosemide; systemic
2.9
7.7
47
177
N06AX21
ATC
duloxetine; oral
3.0
7.6
45
168
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
25.7
7.6
10
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
25.7
7.6
10
*
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
25.7
7.6
10
*
N05AA02
ATC
levomepromazine; systemic
4.8
7.6
24
53
J01DB01
ATC
cefalexin; oral
2.2
7.5
257
2117
ZXE00
NOMESCO Finland
One hour or less
2.0
7.5
124
772
F43.0
ICD-10 Finland
Acute stress reaction
3.8
7.4
31
89
Y04.2
ICD-10 Finland
Assault by bodily force by friend
81.9
7.4
8
*
T00.0
ICD-10 Finland
Superficial injuries involving head with neck
81.9
7.4
8
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
81.9
7.4
8
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
13.8
7.4
12
9
L08
ICPC
Shoulder symptom/complaint
2.7
7.4
55
233
S00.0
ICD-10 Finland
Superficial injury of scalp
11.2
7.4
13
12
Y00.2
ICD-10 Finland
Assault by blunt object by friend
+∞
7.3
7
*
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
+∞
7.3
7
*
P18
ICPC
Medication abuse
16.2
7.3
11
7
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
16.2
7.3
11
7
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.9
7.2
28
76
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.2
7.2
15
19
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
30.8
7.2
9
*
S01.40
ICD-10 Finland
Open wound on the cheek
20.6
7.2
10
5
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.9
7.2
198
1480
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
5.2
7.1
21
43
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
7.1
128
816
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.8
7.1
45
176
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
7.1
76
393
A06AD11
ATC
lactulose; oral
3.3
7.1
35
116
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.6
7.0
17
27
WX402
NOMESCO Finland
General anaesthesia
2.5
7.0
56
249
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
14.2
6.9
11
8
K92.0
ICD-10 Finland
Haematemesis
8.6
6.9
14
17
V03AA01
ATC
NA
9.6
6.8
13
14
Y87.1
ICD-10 Finland
Sequelae of assault
40.9
6.8
8
*
S01.7
ICD-10 Finland
Multiple open wounds of head
40.9
6.8
8
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
6.8
109
667
N06AB05
ATC
paroxetine; oral
3.6
6.7
29
86
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.4
6.7
19
37
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.7
6.7
28
81
M03BC01
ATC
orphenadrine (citrate); systemic
2.1
6.6
86
482
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
6.6
105
638
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
10.3
6.6
12
12
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
6.6
116
731
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.9
6.5
20
43
KMAK
NOMESCO Finland
NA
1.9
6.5
183
1354
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.1
6.5
34
118
S02.69
ICD-10 Finland
Fracture of the lower jaw UNS
71.2
6.4
7
*
S82.6
ICD-10 Finland
Fracture of lateral malleolus
4.0
6.4
24
63
SPAT1307
SPAT
Psychosocial counselling and guidance
2.9
6.4
40
152
SPAT1234
SPAT
Support of social functional capacity
5.4
6.4
18
35
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.0
6.4
36
129
SPAT1211
SPAT
Application of soft bandage
3.2
6.4
32
107
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.4
6.4
29
90
-69
ICPC
Other reason for encounter NEC
5.7
6.4
17
31
SPAT1310
SPAT
Counselling related to known health issue
2.0
6.4
106
650
D11
ICPC
Diarrhoea
2.5
6.4
50
221
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.0
6.4
36
130
J20
ICD-10 Finland
Acute bronchitis
2.9
6.4
37
137
N01
ICPC
Headache
2.6
6.3
47
201
N05AB01
ATC
dixyrazine; systemic
11.3
6.3
11
10
S01.3
ICD-10 Finland
Open wound of ear
18.5
6.3
9
5
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
18.5
6.3
9
5
F19.39
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS
+∞
6.3
6
*
Y00.8
ICD-10 Finland
Assault by blunt object by other known person
+∞
6.3
6
*
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
+∞
6.3
6
*
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
27.3
6.3
8
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
27.3
6.3
8
*
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.9
6.2
24
65
S70.0
ICD-10 Finland
Contusion of hip
6.5
6.2
15
24
N06AA12
ATC
doxepin; systemic
4.9
6.2
19
41
SPAT1240
SPAT
Therapeutic discussion
2.4
6.2
54
253
L17
ICPC
Foot/toe symptom/complaint
2.2
6.1
64
323
SGA01
NOMESCO Finland
Tooth opening as first aid
2.2
6.1
70
369
Z71.8
ICD-10 Finland
Other specified counselling
2.0
6.1
86
497
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
6.1
51
233
N05BE01
ATC
buspirone; oral
5.4
6.1
17
33
P01AB01
ATC
metronidazole; oral, rectal
1.9
6.1
111
702
F39
ICD-10 Finland
Unspecified mood [affective] disorder
5.8
6.1
16
29
M01AB05
ATC
diclofenac; systemic, rectal
1.8
6.0
202
1564
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.8
6.0
38
146
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.3
6.0
21
52
WX892
NOMESCO Finland
Monitored bed care
3.5
6.0
26
78
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020191) Ethanol [Moles/volume] in Serum or Plasma
36
30
13.24
36.44
2.0
1.7
promille
2.1
1.1
1.94
28
24
(3028707) Methadone [Presence] in Urine by Screen method
64
115
6.57
35.51
9.7
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
75
184
4.90
29.36
10.0
2.4
—
—
—
0
0
(4198724)
29
25
12.54
28.61
6.5
1.8
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
27
23
12.62
26.79
2.3
1.8
iu/ml
971080.0
1224630.0
—
5
5
(3032080) INR in Blood by Coagulation assay
176
838
3.18
25.40
7.6
6.1
inr
1.1
1.1
0.18
71
270
(3027008) Opiates [Presence] in Urine
89
277
3.95
25.28
7.7
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
76
213
4.27
24.91
8.6
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
88
275
3.92
24.82
7.8
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
88
278
3.88
24.40
8.0
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
84
260
3.92
23.95
7.6
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
127
535
3.14
22.10
3.4
1.8
%
1.7
1.4
4.04
111
496
(3023368) Bacteria identified in Blood by Culture
129
566
3.01
20.69
5.8
4.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
81
276
3.50
19.76
7.8
1.8
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
28
42
7.15
18.13
4.4
2.1
kpa
8.8
9.2
0.47
28
42
(3013290) Carbon dioxide [Partial pressure] in Blood
28
42
7.15
18.13
4.4
2.1
kpa
5.3
4.9
1.42
28
42
(3012501) Base excess in Blood by calculation
28
42
7.15
18.13
4.4
2.1
mmol/l
3.7
2.7
0.77
22
25
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
171
927
2.63
17.66
9.3
6.2
mmol/l
1.2
1.2
4.58
164
865
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
214
1293
2.64
17.63
7.2
6.2
umol/l
10.4
11.1
0.50
196
1230
(40767503) Oxygen content in Capillary blood by calculation
23
30
8.13
16.75
2.8
2.6
%
16.2
17.2
—
9
14
(46235355) HIV 1 and 2 tests - Meaningful Use set
168
922
2.56
16.66
2.4
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
64
208
3.53
16.64
4.9
2.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
203
1227
2.52
16.24
11.7
7.6
e9/l
0.0
0.0
1.10
164
1000
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
281
1990
2.96
16.13
9.1
7.0
u/l
76.0
75.4
0.10
260
1889
(3013826) Glucose [Moles/volume] in Serum or Plasma
227
1449
2.56
16.09
7.9
4.6
mmol/l
6.5
6.5
0.09
213
1324
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
149
800
2.48
15.16
4.1
2.7
u/l
69.7
54.6
1.66
132
753
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
130
669
2.49
14.36
3.2
2.0
u/l
196.0
291.0
0.45
125
638
(3023183) Ammonium ion [Moles/volume] in Plasma
28
54
5.54
14.15
4.3
5.3
umol/l
32.9
38.0
0.62
23
47
(3003396) Base excess in Arterial blood by calculation
62
218
3.23
14.13
13.2
10.0
mmol/l
1.0
1.4
0.39
48
165
(3017143) Hepatitis C virus Ab [Presence] in Serum
106
499
2.60
14.09
2.0
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
155
870
2.38
14.05
5.5
5.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
123
624
2.48
13.95
3.9
3.9
ph
7.4
7.4
0.04
39
109
(3002173) Hemoglobin [Mass/volume] in Arterial blood
56
188
3.35
13.74
14.3
10.9
g/l
122.9
124.5
0.19
56
178
(3002032) Base excess in Venous blood by calculation
55
183
3.37
13.68
4.1
3.7
mmol/l
1.6
1.9
0.24
49
140
(3030467) Casts [#/volume] in Urine by Automated count
123
631
2.45
13.55
3.6
2.7
e6/l
1.2
0.3
0.79
92
458
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
125
646
2.44
13.55
2.5
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
96
438
2.63
13.55
3.0
2.3
mosm/kgh2o
547.8
573.7
0.39
89
378
(3000991) Gas panel - Venous blood
52
171
3.39
13.16
14.1
7.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
63
234
3.06
13.04
4.8
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
145
812
2.33
12.99
3.9
2.8
—
—
—
0
0
(3012544) pH of Venous blood
55
189
3.26
12.97
4.0
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
122
635
2.40
12.92
3.6
2.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
172
1037
2.27
12.90
10.1
6.9
mmol/l
1.2
1.2
3.74
145
886
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
131
709
2.34
12.64
2.6
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
79
338
2.72
12.59
2.2
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
128
697
2.31
12.08
3.8
2.8
e6/l
19.1
53.3
1.42
102
519
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
55
200
3.07
11.77
2.6
2.7
u/l
10802.2
2953.7
0.35
16
83
(3024561) Albumin [Mass/volume] in Serum or Plasma
158
947
2.20
11.73
5.7
4.8
g/l
35.9
37.1
1.73
149
901
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
63
248
2.87
11.71
3.0
2.4
u/l
34.5
28.5
1.27
51
211
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
79
350
2.62
11.69
1.9
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
110
3.75
11.62
16.0
14.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
196
1292
2.15
11.28
7.2
6.3
%
8.3
8.4
0.09
182
1234
(3009508) Creatinine [Moles/volume] in Urine
130
730
2.23
11.26
6.2
3.2
mmol/l
7.6
8.7
1.29
115
631
(3006504) Eosinophils/100 leukocytes in Blood
194
1282
2.13
10.99
6.7
6.0
%
2.5
2.8
1.70
179
1218
(3019309) Folate [Moles/volume] in Red Blood Cells
70
306
2.60
10.57
1.9
1.6
nmol/l
1219.0
1197.1
0.06
49
244
(3000850) Epithelial cells [#/volume] in Urine
93
464
2.36
10.57
3.0
2.4
e6/l
35.4
5.0
0.87
87
411
(3006315) Basophils [#/volume] in Blood
200
1360
2.07
10.24
7.0
5.9
e9/l
0.0
0.0
1.98
161
1212
(3002030) Lymphocytes/100 leukocytes in Blood
198
1346
2.06
10.09
6.8
6.0
%
27.5
29.1
1.37
182
1284
(3018095) Leukocytes [#/volume] in Urine
139
830
2.11
10.08
4.5
3.2
e6/l
219.0
134.4
0.21
104
557
(3022096) Basophils/100 leukocytes in Blood
186
1243
2.04
9.86
6.6
6.1
%
0.7
0.7
0.20
173
1175
(3001604) Monocytes [#/volume] in Blood
198
1356
2.04
9.78
7.1
5.9
e9/l
0.6
0.6
1.13
161
1207
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
52
4.66
9.70
1.7
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
58
241
2.68
9.66
1.9
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
104
563
2.20
9.63
3.1
2.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
41
5.11
9.43
3.6
2.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
193
1326
1.99
9.27
6.7
5.8
%
56.7
56.6
0.03
179
1268
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
134
3.15
9.14
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
201
1405
1.99
9.14
7.3
6.4
e9/l
0.2
0.2
0.18
170
1268
(3023511) Choriogonadotropin [Units/volume] in Urine
32
97
3.53
9.13
1.8
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
248
2.60
9.10
2.0
1.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
31
93
3.56
8.98
18.9
10.4
mmol/l
24.5
24.6
0.06
31
87
(3019198) Lymphocytes [#/volume] in Blood
201
1411
1.98
8.96
7.1
5.9
e9/l
2.0
1.9
0.55
168
1278
(3044640) Blood type and Crossmatch panel - Blood
128
775
2.02
8.68
2.2
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
127
3.14
8.68
6.1
8.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
135
835
1.99
8.61
4.4
2.7
ng/l
18.4
27.7
0.67
80
450
(3029937) Albumin [Presence] in Urine by Test strip
115
675
2.04
8.47
4.3
3.1
estimate
0.0
0.0
0.69
64
276
(3015736) pH of Urine
157
1028
1.94
8.44
3.4
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
132
820
1.97
8.24
1.9
1.7
pmol/l
88.8
96.0
1.09
77
429
(3013650) Neutrophils [#/volume] in Blood by Automated count
214
1565
1.92
8.13
9.9
9.1
e9/l
4.3
4.0
1.09
180
1388
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
151
988
1.92
8.04
5.4
3.2
u/l
92.1
34.0
0.60
142
934
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
117
702
1.99
8.04
2.0
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
81
425
2.17
7.97
4.8
3.0
ng/l
688.6
425.8
0.25
59
267
(3007853) Bacteria identified in Skin by Aerobe culture
65
312
2.33
7.91
1.8
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
326
2805
2.92
7.85
22.7
11.0
mmol/l
139.4
139.6
0.91
320
2732
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
334
2914
3.37
7.79
19.9
10.6
mg/l
19.2
21.1
0.71
291
2207
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
28
5.55
7.79
2.3
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
36
4.91
7.72
1.5
4.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
95
3.23
7.34
1.8
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
349
2.17
7.01
3.2
2.6
e6/l
2.2
2.7
0.24
30
172
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
275
2240
2.00
6.98
5.3
3.0
u/l
71.5
44.7
2.65
256
2146
(3013707) Erythrocyte sedimentation rate by Westergren method
250
1974
1.89
6.96
3.9
3.5
mm/h
11.0
8.5
2.07
230
1855
(3021879) Hepatitis B virus core Ab [Presence] in Serum
63
318
2.19
6.76
1.9
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
233
1808
1.84
6.76
4.7
3.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
28
5.16
6.76
1.7
2.9
—
—
—
0
0
(3013512) EKG study
95
561
1.95
6.68
3.4
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
309
2647
2.27
6.56
15.9
9.1
ml/min/173m2
97.8
93.6
2.65
252
2135
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
168
1219
1.72
5.83
4.2
4.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
523
0.33
5.78
1.5
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
112
727
1.79
5.74
2.5
3.2
mmol/l
2.4
2.4
0.01
98
655
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
97
608
1.82
5.56
2.1
1.8
mg/l
2.7
0.9
0.56
78
451
(3008152) Bicarbonate [Moles/volume] in Arterial blood
31
126
2.60
5.37
9.8
11.6
mmol/l
24.5
24.3
0.15
31
115
(3021601) Nitrite [Presence] in Urine by Test strip
176
1313
1.67
5.37
4.9
4.1
estimate
0.0
0.0
0.49
67
281
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
256
2112
1.76
5.32
4.2
3.7
pmol/l
14.7
14.5
0.78
235
1975
(3014576) Chloride [Moles/volume] in Serum or Plasma
50
253
2.14
5.31
15.4
7.1
mmol/l
104.3
103.9
0.16
50
248
(3052851) Hemolysis interference index of Serum or Plasma
19
59
3.35
5.25
1.6
3.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
69
396
1.92
5.18
1.6
1.6
pmol/l
436.8
435.0
0.02
50
352
(3035350) Ketones [Presence] in Urine by Test strip
175
1315
1.65
5.11
3.9
2.9
estimate
0.0
0.0
0.00
62
274
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
36
4.01
5.03
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
66
3.15
5.03
1.3
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
35
156
2.38
5.01
1.5
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
76
456
1.85
4.97
1.5
1.4
nmol/l
17.5
21.0
1.78
68
400
(3009261) Glucose [Presence] in Urine by Test strip
175
1322
1.64
4.95
4.0
2.9
estimate
0.0
0.0
0.00
64
262
(3017181) Myelocytes/100 leukocytes in Blood
43
211
2.18
4.93
3.5
4.4
%
0.8
0.8
—
10
62
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
372
1.91
4.91
3.0
2.5
e6/l
0.7
0.8
0.14
25
196
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
92
587
1.76
4.91
2.3
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
84
532
1.76
4.57
1.8
2.0
mg/l
3.1
2.9
0.25
66
452
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
156
2.30
4.57
1.4
1.4
miu/ml
348.2
274.2
0.45
11
88
(3019832) Treponema pallidum Ab [Presence] in Serum
83
524
1.76
4.57
1.9
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
54
298
1.96
4.53
2.5
3.0
umol/l
7.7
8.4
0.10
43
252
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
39
3.70
4.53
2.5
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
27
112
2.53
4.51
3.1
3.7
g/l
130.7
131.8
0.08
27
112
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
106
2.57
4.49
1.7
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
221
1795
1.61
4.46
3.5
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
52
3.17
4.13
3.5
3.3
%
58.2
57.9
0.03
16
52
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
52
3.17
4.13
3.4
3.2
e9/l
4.6
4.4
0.09
16
52
(3009343) pH of Capillary blood
29
130
2.34
4.12
3.3
3.0
ph
7.5
7.4
—
5
14
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
28
125
2.35
4.02
3.2
3.0
mmol/l
1.4
1.2
0.12
21
94
(40758558) Short blood count panel - Blood
95
645
1.64
3.96
6.6
6.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
66
2.82
3.81
1.5
1.4
ug/g
179.2
285.0
—
6
37
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
290
2566
1.70
3.73
5.1
4.2
mu/l
1.6
1.8
1.41
272
2420
(3022217) INR in Platelet poor plasma by Coagulation assay
40
213
1.99
3.72
9.9
17.1
inr
1.1
1.2
—
5
37
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
91
2.51
3.71
1.4
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
28
131
2.23
3.62
1.9
3.3
e9/l
65.1
75.2
0.58
16
94
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
9
7.91
3.57
1.9
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
9
7.91
3.57
1.4
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
51
299
1.82
3.56
1.8
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
189
2.01
3.49
3.9
4.6
%
0.0
0.1
—
6
45
(3041096) Erythrocytes [Presence] in Urine by Automated
111
806
1.55
3.43
3.7
2.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
133
1006
1.51
3.40
2.3
2.3
nmol/l
68.5
72.8
0.80
120
939
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
59
2.79
3.37
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
194
1.95
3.25
3.8
4.3
%
1.0
0.5
—
7
43
(3021440) Promyelocytes/100 leukocytes in Blood
36
196
1.93
3.16
3.9
4.6
%
0.0
0.2
—
6
54
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
136
1047
1.48
3.15
4.2
2.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
20
4.59
3.13
1.9
13.7
mmol/l
4.8
7.3
—
9
15
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
39
3.15
3.12
1.3
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
35
190
1.93
3.10
1.8
3.6
%
2.1
1.8
0.43
27
173
(40761511) CBC panel - Blood by Automated count
333
3129
1.99
2.69
17.5
9.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
32
3.19
2.66
6.4
11.1
mmol/l
0.5
0.6
—
10
32
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
294
2684
1.55
2.52
4.1
3.4
mmol/l
5.9
5.7
0.94
268
2506
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
56
372
1.60
2.51
1.9
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
114
881
1.43
2.49
1.5
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
16
4.44
2.48
2.1
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
22
3.69
2.37
1.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
17
4.18
2.37
3.7
2.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
17
4.18
2.37
1.9
2.5
%
10.4
13.3
—
7
17
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
141
1.91
2.34
1.6
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
52
345
1.59
2.34
2.1
2.6
mmol/l
2.4
2.4
0.05
44
306
(3011397) Hemoglobin [Presence] in Urine by Test strip
76
551
1.48
2.30
3.5
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
79
579
1.47
2.26
4.1
2.9
kg/l
1.0
1.0
—
6
69
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
9
5.62
2.22
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
9
5.62
2.22
1.8
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
24
3.39
2.19
1.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
414
0.55
2.16
1.5
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
19
3.74
2.16
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
19
3.74
2.16
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
93
710
1.42
2.14
5.6
4.5
—
—
—
0
0
(3020891) Body temperature
17
82
2.13
2.10
7.5
4.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
24
132
1.88
2.09
5.2
4.2
ng/l
93.7
78.3
0.29
24
122
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
15
4.05
2.04
1.5
1.4
pg
30.3
33.5
—
6
15
(3021788) Differential panel - Synovial fluid
8
26
3.12
2.02
1.0
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
134
1.85
2.01
2.4
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
157
1.78
1.99
1.2
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
21
3.38
1.97
1.0
1.1
iu/ml
206.2
174.9
—
7
21
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
21
3.38
1.97
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
45
2.49
1.95
1.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
11
4.59
1.94
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
11
4.59
1.94
1.8
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
104
1283
0.73
1.92
2.5
2.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
255
2764
0.73
1.91
3.5
3.3
mmol/l
1.4
1.3
0.63
238
2608
(3022948) Iron [Moles/volume] in Serum or Plasma
49
337
1.53
1.91
2.5
2.3
umol/l
13.2
15.1
1.01
42
311
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
46
2.44
1.87
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
46
2.44
1.87
1.8
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
17
3.57
1.84
1.0
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
12
4.21
1.83
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
188
1.65
1.72
1.5
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
63
467
1.42
1.70
1.2
1.2
u/ml
7.1
6.1
0.08
23
190
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
60
442
1.43
1.67
3.3
2.7
ng/l
1472.7
575.5
1.26
47
347
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
31
2.62
1.67
1.4
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
322
1.49
1.66
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
14
3.61
1.62
1.2
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
32
2.53
1.60
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
20
3.03
1.58
3.2
2.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
50
2.24
1.58
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
282
0.55
1.58
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
91
726
1.34
1.58
1.3
1.3
u/ml
0.8
1.7
0.88
26
206
(3048689) Calprotectin [Mass/mass] in Stool
57
421
1.42
1.57
2.2
2.4
ug/g
107.4
125.7
0.28
46
336
(3027273) Bicarbonate [Moles/volume] in Venous blood
17
93
1.87
1.54
4.4
4.0
mmol/l
25.9
24.5
1.19
17
93
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
155
1.66
1.51
1.3
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
44
312
1.47
1.50
2.6
2.3
g/l
2.5
2.4
0.23
38
290
(3005719) IgG [Mass/volume] in Serum or Plasma
32
212
1.56
1.49
1.5
2.0
g/l
11.6
10.4
0.93
26
193
(3001122) Ferritin [Mass/volume] in Serum or Plasma
146
1253
1.28
1.47
2.6
2.7
ug/l
117.3
106.4
0.22
135
1183
(3022313) Gas panel - Capillary blood
17
95
1.83
1.45
3.9
2.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
59
2.07
1.45
1.2
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
16
3.15
1.44
1.2
1.4
mmol/l
5.9
6.7
—
5
16
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
16
3.15
1.44
1.4
1.8
%
91.2
120.8
—
5
16
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
142
1.66
1.42
1.2
1.5
u/l
10.8
7.9
0.57
18
119
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
81
1.89
1.42
1.3
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
53
2.11
1.40
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
29
2.44
1.40
1.6
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
269
2858
0.76
1.39
3.8
3.6
mmol/l
1.4
1.4
0.49
253
2701
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
184
1.57
1.36
1.4
1.4
iu/l
19.3
20.8
0.08
20
153
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
17
2.97
1.36
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
24
2.52
1.31
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
24
2.52
1.31
1.8
3.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
42
306
1.42
1.27
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
70
1.89
1.25
1.5
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
54
412
1.37
1.25
1.2
1.4
titre
297.1
499.7
—
7
77
(3037121) Protein [Mass/volume] in Urine
15
85
1.80
1.25
4.7
3.6
g/l
0.2
0.4
—
10
41
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
485
1.34
1.23
1.3
1.3
iu/ml
17.1
22.5
0.37
16
161
(3044941) Cell count panel - Synovial fluid
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
38
2.13
1.19
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
250
1.44
1.18
8.0
7.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
183
1.51
1.17
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
18
111
1.65
1.14
2.2
2.5
e6/l
0.1
0.1
0.12
18
105
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
88
1.74
1.13
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
31
2.28
1.11
1.0
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
32
2.21
1.08
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
76
630
1.26
0.99
2.0
2.4
umol/l
330.7
4144.6
1.74
65
570
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
23
2.19
0.98
1.4
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
274
2871
0.80
0.96
3.8
3.6
mmol/l
4.6
4.7
1.99
257
2724
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
85
1.67
0.95
1.3
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
51
1.78
0.95
1.1
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
38
288
1.36
0.94
2.9
2.3
%
22.5
25.7
0.54
33
251
(40768800) Prostate Pathology biopsy report
6
27
2.24
0.94
1.5
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
345
3377
1.70
0.94
27.7
15.3
fl
90.8
89.9
2.93
345
3341
(3035941) MCH [Entitic mass]
345
3377
1.70
0.94
27.5
15.3
pg
30.4
30.2
1.94
345
3340
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
93
797
1.23
0.91
1.9
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
56
1.81
0.88
1.5
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
44
1.84
0.86
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
214
0.64
0.86
1.3
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
345
3382
1.65
0.85
28.0
15.4
g/l
136.3
140.0
4.88
345
3344
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
45
1.80
0.85
1.3
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
31
1.95
0.84
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
31
1.95
0.84
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
114
0.52
0.84
1.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
97
1.57
0.82
1.6
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
260
2465
1.20
0.81
4.8
4.4
mmol/mol
38.7
38.4
0.18
242
2356
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
24
2.10
0.75
1.6
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
24
2.10
0.75
2.4
2.2
e6/l
595.0
670.5
—
5
19
(3007164) IgA [Mass/volume] in Serum or Plasma
75
642
1.21
0.74
1.3
1.3
g/l
2.4
2.4
0.01
44
420
(40768443) Skin Pathology biopsy report
15
100
1.52
0.74
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
100
1.52
0.74
1.6
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
38
1.86
0.74
1.1
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
60
1.69
0.73
3.4
5.7
—
557.1
—
0
11
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
26
1.94
0.71
1.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
116
0.60
0.69
1.1
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
59
1.54
0.69
1.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
59
1.54
0.69
1.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
77
667
1.20
0.68
1.6
1.7
mmol/l
1.5
1.5
0.09
68
585
(4034850)
5
91
0.54
0.68
14.0
10.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
79
1.54
0.63
1.3
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
79
1.54
0.63
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
96
1.48
0.62
1.5
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
51
1.58
0.61
1.3
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
115
0.60
0.58
1.1
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.2
—
33.7
—
0
17
(3041354) Potassium [Moles/volume] in Venous blood
0
23
0.00
0.58
0.0
2.6
—
3.9
—
0
23
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
23
0.00
0.58
0.0
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
23
0.00
0.58
0.0
2.6
—
106.1
—
0
23
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
159
0.68
0.55
1.1
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
342
1.22
0.54
1.6
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
66
1.53
0.53
1.3
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
258
2481
1.14
0.52
4.1
3.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
180
1.30
0.51
2.1
2.6
ml/min/173m2
82.4
77.4
—
8
76
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
67
1.51
0.50
1.3
1.7
—
—
—
0
0
(3019225) pH of Specimen
23
181
1.29
0.49
6.0
4.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
84
0.59
0.46
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
84
0.59
0.46
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
64
567
1.16
0.45
4.2
3.5
mg/l
72.9
199.1
0.53
47
379
(3045424) Erythrocytes [Presence] in Urine
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
67
597
1.15
0.44
5.8
4.2
mg/mmol
14.7
12.7
0.12
48
394
(3020961) Endomysium IgA Ab [Titer] in Serum
20
158
1.28
0.42
1.1
1.1
—
134.0
—
0
5
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
222
1.23
0.42
1.2
1.2
iu/ml
242.3
150.0
—
9
94
(3035637) Corticotropin [Mass/volume] in Plasma
5
32
1.57
0.42
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
58
1.39
0.42
1.0
1.1
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
260
1.21
0.41
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
270
0.80
0.41
1.2
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.8
2.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
102
0.68
0.40
1.1
1.1
—
7.6
—
0
17
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
282
2890
0.88
0.39
4.0
3.8
mmol/l
2.7
2.9
2.14
258
2724
(3004588) Protein electrophoresis panel - Serum or Plasma
13
98
1.34
0.38
2.5
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
113
0.70
0.37
1.6
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
107
1.32
0.37
1.0
1.3
—
3.9
—
0
7
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
115
0.69
0.37
2.1
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
37
1.36
0.37
1.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.37
1.0
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
41
1.47
0.36
1.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
77
0.64
0.36
2.2
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
44
1.37
0.34
2.0
2.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.0
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
46
515
0.88
0.32
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
101
1.30
0.32
1.3
1.4
—
—
—
0
0
(4306422)
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.1
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
96
0.72
0.31
1.3
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
176
1.21
0.29
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
57
1.23
0.29
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
31
352
0.87
0.27
1.1
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
66
1.22
0.27
1.4
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
95
1.27
0.26
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
15
181
0.82
0.26
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
78
1.29
0.24
1.6
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
40
442
0.89
0.24
2.4
2.3
ug/l
0.5
0.7
1.93
28
225
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
84
0.71
0.24
1.2
1.2
—
3.2
—
0
10
(3050129) First trimester maternal screen panel - Serum or Plasma
15
179
0.83
0.23
1.2
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
22
190
1.17
0.23
4.8
2.5
e9/l
4.6
4.1
0.40
12
166
(3014051) Protein [Presence] in Urine by Test strip
5
38
1.32
0.23
1.6
1.6
—
—
—
0
0
(4268621)
5
39
1.29
0.23
2.0
2.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
94
0.74
0.22
2.1
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
95
0.73
0.22
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
95
0.73
0.22
1.3
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
40
1.25
0.22
1.0
2.5
%
3.0
1.7
—
5
30
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
55
594
0.91
0.22
3.5
3.1
%
20.3
22.4
0.44
23
194
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
9.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
25.7
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
32.9
—
0
7
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
96
1008
0.93
0.20
2.0
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
132
0.83
0.18
2.4
2.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
7
59
1.19
0.18
1.4
1.2
ug/l
2.3
3.2
—
7
53
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
60
1.17
0.18
1.0
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
296
2922
1.08
0.18
19.4
11.0
%
40.6
41.5
1.52
217
2430
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
142
0.84
0.18
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
142
0.84
0.18
1.1
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
32
292
1.11
0.17
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
68
0.73
0.17
1.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
141
0.85
0.16
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
141
0.85
0.16
1.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
116
0.86
0.12
1.6
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
270
1.08
0.11
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
45
1.11
0.10
1.2
2.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
47
1.06
0.09
4.2
2.1
—
1.1
—
0
5
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
48
502
0.95
0.09
1.6
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
58
1.04
0.08
7.7
1.9
nmol/l
0.5
1.0
—
6
52
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
72
0.83
0.07
1.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
84
0.83
0.07
1.7
2.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
87
1.04
0.07
2.0
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
10
89
1.13
0.07
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
179
1.06
0.05
2.4
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
76
747
1.02
0.03
4.0
3.3
ug/l
1.4
1.5
0.31
69
693
(4035726)
17
179
0.95
0.03
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
162
1.05
0.02
5.0
3.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
128
1.02
0.00
1.5
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
101
0.99
0.00
1.4
1.1
—
—
—
0
0
(4010399)
17
173
0.98
0.00
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
205
0.97
0.00
1.8
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
26
256
1.02
0.00
3.4
3.5
%
32.4
30.5
0.30
18
177
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
36.2
—
0
6
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.5
—
0
6
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.8
—
61.8
—
0
6
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
68
0.88
0.00
1.3
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
99
0.91
0.00
1.4
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
19
190
1.00
0.00
1.2
1.3
—
25.3
—
0
12
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
2.2
—
0
8
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
64
0.94
0.00
1.2
1.2
—
1.0
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
69
1.01
0.00
1.1
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.8
—
28.6
—
0
5
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
8.2
—
0
7
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
69
1.01
0.00
1.7
1.1
—
12.8
—
0
7
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_ASSAU_OTHER_SPECIFE_MEANS – Assault by other specified means
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).